Literature DB >> 35705453

Defining and characterising a toolkit for the development of a successful European registry for rare liver diseases: a model for building a rare disease registry.

Marinos Pericleous1, Claire Kelly2, Michael Schilsky3, Anil Dhawan4, Aftab Ala5.   

Abstract

INTRODUCTION: A rare disease is defined by the European Health Commission as a disorder affecting less than 5/10,000 of the population. There are at least 20 rare liver diseases (RLDs) seen frequently in the adult and paediatric liver clinic, signifying that the hepatology community can be influential in developing such patient databases for registering patients with rare hepatic conditions. The aim of this review was, first, to identify registries for RLDs in Europe, and, second, to design a universal blueprint for the development of a registry for RLD by using lessons learnt from the European registries that have already been established.
METHODS: We searched PubMed, Google Scholar and clinicaltrials.gov using the MESH terms 'registries', 'database management systems', 'database' and the non-MESH terms 'database$', 'registry', 'repository' and 'repositories'. We only included studies in English from countries/consortia of the European Union (EU). Our literature search was performed in 2020.
RESULTS: We identified 37 registries for RLDs in Europe. Using information from the design of these registries we designed a blueprint for the development of a patient registry for an RLD consisting of a theoretical, technical and maintenance phase. DISCUSSION: It is believed that rare diseases may affect as much as 6-8% of the EU population across its 28 member states. Here we have provided a toolkit for designing a registry for an RLD. Our article will complement the efforts of loco-regional, national and international groups seeking to establish robust systems for data collection and analysis for orphan liver diseases. © Royal College of Physicians 2022. All rights reserved.

Entities:  

Keywords:  patient registries; rare liver diseases

Year:  2022        PMID: 35705453      PMCID: PMC9345223          DOI: 10.7861/clinmed.2021-0725

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   5.410


  20 in total

1.  Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis.

Authors:  A Jacoby; A Rannard; D Buck; N Bhala; J L Newton; O F W James; D E J Jones
Journal:  Gut       Date:  2005-06-16       Impact factor: 23.059

2.  EASL clinical practice guidelines for HFE hemochromatosis.

Authors: 
Journal:  J Hepatol       Date:  2010-04-18       Impact factor: 25.083

3.  Using an 'action set' for the management of acute upper gastrointestinal bleeding.

Authors:  Marinos Pericleous; Charles Murray; Mark Hamilton; Owen Epstein; Rupert Negus; Tim Peachey; Arvind Kaul; James O'Beirne
Journal:  Therap Adv Gastroenterol       Date:  2013-11       Impact factor: 4.409

4.  The imperative for patient-centred research to develop better quality services in rare diseases.

Authors:  Karen Facey; Helle Ploug Hansen
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

5.  Development and progress of the National Congenital Anomaly and Rare Disease Registration Service.

Authors:  Sarah Stevens; Nicola Miller; Jem Rashbass
Journal:  Arch Dis Child       Date:  2017-10-24       Impact factor: 3.791

6.  An integrated care pathway improves quality of life in Primary Biliary Cirrhosis.

Authors:  David E J Jones; Katy Sutcliffe; Jessie Pairman; Katharine Wilton; Julia L Newton
Journal:  QJM       Date:  2008-04-03

Review 7.  Patient reported outcome measures in rare diseases: a narrative review.

Authors:  Anita Slade; Fatima Isa; Derek Kyte; Tanya Pankhurst; Larissa Kerecuk; James Ferguson; Graham Lipkin; Melanie Calvert
Journal:  Orphanet J Rare Dis       Date:  2018-04-23       Impact factor: 4.123

8.  Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web Layer.

Authors:  Pedro Sernadela; Lorena González-Castro; Claudio Carta; Eelke van der Horst; Pedro Lopes; Rajaram Kaliyaperumal; Mark Thompson; Rachel Thompson; Núria Queralt-Rosinach; Estrella Lopez; Libby Wood; Agata Robertson; Claudia Lamanna; Mette Gilling; Michael Orth; Roxana Merino-Martinez; Manuel Posada; Domenica Taruscio; Hanns Lochmüller; Peter Robinson; Marco Roos; José Luís Oliveira
Journal:  Biomed Res Int       Date:  2017-10-29       Impact factor: 3.411

9.  Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia.

Authors:  Dalibor Stanimirovic; Eva Murko; Tadej Battelino; Urh Groselj
Journal:  Orphanet J Rare Dis       Date:  2019-07-09       Impact factor: 4.123

Review 10.  Establishing Patient Registries for Rare Diseases: Rationale and Challenges.

Authors:  Vanessa Boulanger; Marissa Schlemmer; Suzanne Rossov; Allison Seebald; Pamela Gavin
Journal:  Pharmaceut Med       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.